ORGO

2.59

1.17% 0.03

Dopo l'orario di chiusura: 2.57 -0.02 -0.77%

Organogenesis Holdings Inc (ORGO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$2.56

Aprire:

$2.56

Volume 24 ore:

1.34M

Relative Volume:

1.11

Capitalizzazione di mercato:

$333.27M

Reddito:

$564.17M

Utile/perdita netta:

$37.03M

Rapporto P/E:

23.65

EPS:

0.1095

Flusso di cassa netto:

$-24.46M

1 W Prestazione:

+7.92%

1M Prestazione:

+15.62%

6M Prestazione:

-34.76%

1 anno Prestazione:

-51.32%

Intervallo 1D:

$2.54

$2.645

Intervallo di 1 settimana:

$2.275

$2.73

Portata 52W:

$2.21

$7.0771

Organogenesis Holdings Inc Stock (ORGO) Company Profile

Nome

Organogenesis Holdings Inc

Settore

Healthcare (1106)

Industria

Drug Manufacturers - Specialty & Generic (84)

Telefono

781-575-0775

Indirizzo

85 DAN ROAD, CANTON, MA

Dipendente

854

Cinguettio

Prossima data di guadagno

2026-05-07

Ultimi documenti SEC

ORGO's Discussions on Twitter

Compare ORGO vs TAK, ZTS, TEVA, HLN, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ORGO Organogenesis Holdings Inc	2.59	329.41M	564.17M	37.03M	-24.46M	0.1095
TAK Takeda Pharmaceutical Co Adr	16.55	52.32B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	112.54	47.38B	9.47B	2.67B	2.28B	6.0218
TEVA Teva Pharmaceutical Industries Ltd Adr	35.86	41.16B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.17	41.02B	14.54B	2.22B	2.58B	0.4871
UTHR United Therapeutics Corp	572.20	24.67B	3.18B	1.33B	1.04B	27.90

Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-06-28	Iniziato	Lake Street	Buy
2024-02-07	Iniziato	Cantor Fitzgerald	Overweight
2023-06-15	Iniziato	Morgan Stanley	Equal-Weight
2023-05-24	Aggiornamento	BTIG Research	Neutral → Buy
2022-11-10	Downgrade	BTIG Research	Buy → Neutral
2022-08-10	Downgrade	Oppenheimer	Outperform → Perform
2020-01-10	Iniziato	SVB Leerink	Outperform
2019-08-26	Ripresa	Credit Suisse	Outperform
2019-05-02	Iniziato	Credit Suisse	Outperform
2019-04-17	Iniziato	Oppenheimer	Outperform
2019-04-11	Iniziato	SunTrust	Buy

Mostra tutto

Organogenesis Holdings Inc Borsa (ORGO) Ultime notizie

May 01, 2026

ORGO Price Today: Organogenesis Holdings Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

May 01, 2026

Apr 30, 2026

[ARS] Organogenesis Holdings Inc. SEC Filing - Stock Titan

Apr 30, 2026

Organogenesis (NASDAQ: ORGO) details 2026 virtual meeting, pay and audit votes - Stock Titan

Apr 30, 2026

Organogenesis Completes Rolling Submission of Biologics License Application for ReNu® - Orthopedics This Week

Apr 30, 2026

Organogenesis (ORGO) Projected to Post Earnings on Thursday - MarketBeat

Apr 30, 2026

Apr 29, 2026

Organogenesis completes biologics license application for knee OA By Investing.com - Investing.com India

Apr 29, 2026

Organogenesis completes biologics license application for knee OA - Investing.com UK

Apr 29, 2026

Apr 28, 2026

Organogenesis Holdings Inc. Completes Biologics License Application Submission for ReNu® to Treat Knee Osteoarthritis - Quiver Quantitative

Apr 28, 2026

ORGO stock rallies after hours on clearing regulatory pathway for pain relief treatment - MSN

Apr 27, 2026

Apr 26, 2026

Organogenesis shares jump 20% following positive clinical trial results - MSN

Apr 26, 2026

Apr 24, 2026

Organogenesis (ORGO) CCO exercises option, now holds 900,682 shares - Stock Titan

Apr 24, 2026

Tissue Engineering Market to Grow at 12.95% CAGR Reaching USD 27.59 Billion by 2031, Driven by Advances in Regenerative Medicine and Biomaterials, Says Mordor Intelligence - GlobeNewswire Inc.

Apr 24, 2026

Apr 23, 2026

Organogenesis Holdings Q3 2025 Earnings Preview - MSN

Apr 23, 2026

Apr 20, 2026

Organogenesis Holdings (ORGO) Stock Dark Pool Activity (Trend Weakens) 2026-04-20Shared Trade Ideas - Cổng thông tin điện tử Tỉnh Sơn La

Apr 20, 2026

Apr 17, 2026